Titan Biotech (BOM:524717) EV-to-EBIT : 14.00 (As of Jun. 01, 2025)

View and export this data going back to 2000. Start your Free Trial

What is Titan Biotech EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Titan Biotech's Enterprise Value is ₹3,716 Mil. Titan Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₹265 Mil. Therefore, Titan Biotech's EV-to-EBIT for today is 14.00.

The historical rank and industry rank for Titan Biotech's EV-to-EBIT or its related term are showing as below:

BOM:524717' s EV-to-EBIT Range Over the Past 10 Years
Min: 2.61 Med: 8.33 Max: 24.47
Current: 14

During the past 13 years, the highest EV-to-EBIT of Titan Biotech was 24.47. The lowest was 2.61. And the median was 8.33.

BOM:524717's EV-to-EBIT is ranked worse than
56.6% of 470 companies
in the Biotechnology industry
Industry Median: 8.875 vs BOM:524717: 14.00

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Titan Biotech's Enterprise Value for the quarter that ended in Dec. 2024 was ₹6,055 Mil. Titan Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₹265 Mil. Titan Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 4.38%.

Titan Biotech EV-to-EBIT Historical Data

The historical data trend for Titan Biotech's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Biotech EV-to-EBIT Chart

Titan Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-EBIT

Get a 7-Day Free Trial

4.78

3.77

7.37

5.80

13.61

Titan Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial															10.44	13.61	15.31	18.39	22.81

Competitive Comparison of Titan Biotech's EV-to-EBIT

For the Biotechnology subindustry, Titan Biotech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Titan Biotech's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Titan Biotech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Titan Biotech's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Titan Biotech EV-to-EBIT Calculation

Titan Biotech's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	3716.386	/	265.464
	=	14.00

Titan Biotech's current Enterprise Value is ₹3,716 Mil.
Titan Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹265 Mil.

Titan Biotech (BOM:524717) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Titan Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 )	=	EBIT	/	Enterprise Value (Q: Dec. 2024 )
	=	265.464	/	6055.446
	=	4.38 %

Titan Biotech's Enterprise Value for the quarter that ended in Dec. 2024 was ₹6,055 Mil.
Titan Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹265 Mil.

Titan Biotech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Titan Biotech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Titan Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Titan Biotech Ltd (BOM:524717) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi, IND, 110034

Website

https://www.titanbiotechltd.com

Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The Company's business activity falls within a single primary business segment which is business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.

Titan Biotech Headlines

No Headlines